Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
VANCOUVER – QLT Inc. (TSX:QLT) said Monday it has signed an option agreement with Mati Therapeutics Inc., a company associated with former QLT chief executive Robert Butchofsky, for its punctal plug drug delivery system.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.